Effects of dietary fish oil replacement with blended vegetable oils on growth,lipid metabolism and antioxidant capacity of subadult swimming crab Portunus trituberculatus

A 120‐day trial was conducted to assess the effects of dietary fish oil replacement with vegetable oils on growth, lipid metabolism and antioxidant capacity of subadult swimming crab Portunus trituberculatus. Five isonitrogenous and isolipidic diets were formulated to replace 0, 250, 500, 750 and 1000g/kg of fish oil with a mixture of soybean and rapeseed oil (defined as D1–D5), and each treatment had 30 replicate crabs. Dietary fish oil replacement had no significant effects on growth of the crabs, while the D3 had the highest hepatosomatic index and total lipids in hepatopancreas. The triglyceride and lipase activities in hepatopancreas increased significantly with increasing dietary fish oil replacement. The D4 had the highest levels of alkaline phosphatase (ALP) and acid phosphatase (ACP) in the hepatopancreas, as well as the haemolymph ALP, ACP and peroxidase. The highest levels of haemolymph total antioxidant capacity, catalase and malondialdehyde were detected in D1. Total n‐3 polyunsaturated fatty acids levels in hepatopancreas decreased significantly with increasing dietary fish oil replacement. In conclusion, dietary fish oil replacement had no significant effects on growth of P. trituberculatus, and 500g/kg of fish oil replacement could improve antioxidant capacity, but excessive replacement level will enhance lipid accumulation and peroxidation in the hepatopancreas.     

Effects of different carbon sources and dietary protein levels in a biofloc system on growth performance,immune response against white spot syndrome virus infection and cathepsin L gene expression of Litopenaeus vannamei

A 5‐week study was performed to evaluate the effect of spoilage date extract (SDE) as the biofloc carbon source on Litopenaeus vannamei (5.4 ± 0.3 g) performance. The two levels of dietary protein (15% and 25% crude protein) and two carbohydrate sources (molasses‐M and SDE‐P) were tested including: M15, M25, P15 and P25. The minimum (0.2 ± 0.0 mg/L) and the maximum (0.5 ± 0.0 mg/L) of total ammonia nitrogen were observed in the P15 and M25 groups respectively. The highest protein efficiency ratio (6.1 ± 0.3) and protein productive value (112.3 ± 5.8%) were found in the P15 group (p < 0.05). No significant difference was found between biofloc treatments in the expression of cathepsin L gene in hepatopancreas (p > 0.05). The number of total haemocyte count (THC), semigranular cells (SGC) and granular cells (GC) of shrimp in SDE‐based biofloc treatments was relatively higher than those in molasses‐based biofloc treatments. Following the white spot syndrome virus (WSSV) challenge, a significant decrease in THC, SGC, GC and hyaline cell values was observed in all treatments (p = 0.001). Plasma biochemical parameters were significantly influenced by dietary protein levels, biofloc carbon sources as well as WSSV challenge test. In conclusion, SDE successfully could be used as an alternative carbon source for establishing a biofloc system in L. vannamei production.     

Tulathromycin enhances humoral but not cellular immune response in pigs vaccinated against swine influenza

The effect of a standard, single dose therapy with tulathromycin was investigated on the postvaccinal humoral and cellular immune response in pigs vaccinated against swine influenza. Forty‐five pigs, divided into 3 groups, were used (control not vaccinated (C, n = 15), control vaccinated (CV, n = 15), and experimentally received tulathromycin (TUL, n = 15)). For vaccination of pigs, an inactivated, commercial vaccine was used. Pigs from TUL group received single dose of tulathromycin intramuscularly, at the recommended dose (2.5 mg/kg body weight). Pigs from TUL and CV groups were vaccinated at 8 and 10 weeks of age. The specific humoral and cellular immune response against swine influenza virus (SIV) was evaluated. The results of present study showed that humoral postvaccinal response after vaccination against SIV can be modulated by treatment with tulathromycin. In pigs from TUL group, the significantly higher titers of anti‐SIV‐specific antibodies were observed 4 and 6 weeks after booster dose of vaccine. Simultaneously, T‐cell‐mediated immune response against SIV was not affected by tulathromycin. Our recent study confirmed the importance of defining the modulatory activity of tulathromycin because of its influence on the immune response to vaccines. Since the antibodies against hemagglutinin are crucial for the protection against SIV, the present observations should prompt further studies on the practical significance of recent results in terms of clinical implications (postvaccinal protection) in the field conditions.     

怀山药皮对淇河鲫血清生化、免疫指标及组织结构的影响

为探究怀山药皮(Chinese yam peel,YP)对淇河鲫免疫的影响,选取平均体重为(106.76±3.74)g的淇河鲫240尾,随机分为对照组(NC)、0.5%怀山药皮添加组(LYP)、1%怀山药皮添加组(MYP)、2%怀山药皮添加组(HYP)4组,养殖8周,检测实验鱼生长指标、血清生化指标及免疫相关基因的表达情况。结果显示:添加怀山药皮对淇河鲫生长指标没有显著性影响;血液生化指标中谷草转氨酶活性在MYP组显著性降低,碱性磷酸酶的活性显著升高;与NC组相比,怀山药皮添加组肝脏细胞膜与核膜完整性增强,胞质破碎,核溶解、偏移现象减轻;与NC组相比,添加怀山药皮上调了抑炎因子(IL-10)、紧密连接蛋白基因(Claudin-1)、抗氧化基因(CAT和GST)和TLR通路基因(TLR4)mRNA表达量。以上结果表明,饲料中添加怀山药皮,能在一定程度上增强鱼体免疫力。     

固态发酵醋糟饲料对育肥猪生长性能、养分表观消化率、血清指标及粪便中挥发性脂肪酸含量的影响

本试验旨在研究固态发酵醋糟饲料(SFVD)对育肥猪生长性能、养分表观消化率、血清指标及粪便中挥发性脂肪酸(VFA)含量的影响。选择体况相近[(59.04±0.33)kg]的健康“杜×长×大”三元杂交生长育肥猪60头,随机分为2个组,每组3个重复,每个重复10头猪。对照组饲喂基础饲粮+150 mg/kg土霉素钙,试验组饲喂基础饲粮+5%的SFVD。预试期6 d,正试期35 d。结果表明:与对照组相比,基础饲粮中添加5%的SFVD对育肥猪平均日采食量(ADFI)具有一定的促进趋势(P=0.056);显著降低了育肥猪饲粮中干物质(DM)、粗蛋白质(CP)、有机物(OM)和总能(GE)的表观消化率(P<0.05),对粗脂肪(EE)表观消化率有一定的促进趋势(P=0.052);显著提高了育肥猪血清谷草转氨酶(AST)和谷胱甘肽过氧化物酶(GSH-Px)活性(P<0.05),血清高密度脂蛋白(HDL)和免疫球蛋白A(IgA)含量也呈现出一定的升高趋势(P=0.055和P=0.077);显著提高了育肥猪粪便中丙酸含量(P<0.05),粪便中甲酸和总挥发性脂肪酸(TVFA)含量也呈现出一定的升高趋势(P=0.071和P=0.054)。由此可见,基础饲粮中添加5%的SFVD对育肥猪生长性能、肠道健康及免疫性能的提高具有潜在的促进作用。     

复方中草药添加剂对稻鸭共作模式下成都麻鸭生理效应的影响研究

为研究复方中草药添加剂对稻鸭共作模式下成都麻鸭生长性能、血清生化指标、抗氧化指标及免疫指标的影响,试验选取体重相近、体况健康的15日龄成都麻鸭240只,随机分为4组,每组5个重复,每个重复12只。4组为对照组饲喂基础饲粮;试验1、2、3组在基础饲粮中按照质量比分别添加0.5%(低剂量组)、1%(中剂量组)、2%(高剂量组)的复方中草药,试验期90 d。结果显示:(1)试验1、2、3组的平均日增重分别较对照组提高2.19%、4.34%、4.98%(P<0.05);试验2、3组的料重比分别较对照组降低3.37%、3.63%(P<0.05);(2)试验2组和3组的总蛋白(TP)分别较对照组提高4.20%、6.08%(P<0.05);试验2组和3组的尿素氮(BUN)分别较对照组降低12.72%、16.36%(P<0.05);试验2组和3组的谷草转氨酶(ALT)分别较对照组降低15.84%、19.22%(P<0.05);试验3组的谷丙转氨酶(AST)较对照组降低19.34%(P<0.05);(3)试验2组和3组超氧化物歧化酶(SOD)分别较对照组提高15.80%、20.00%(P<0.05);试验3组的总抗氧化能力(T-AOC)较对照组提高22.37%(P<0.05);(4)三个试验组的IgA、IgM、IgG、IFN-γ、IL-2显著高于对照组(P<0.05),试验2组的肿瘤坏死因子-α(TNF-α)较对照组提高10.06%(P<0.05),试验2组和3的组溶菌酶(LZM)分别较对照组提高6.79%、5.66%(P<0.05)。综上,中草药添加剂能有效提高稻鸭共作模式下成都麻鸭的生长性能、血清生化指标、抗氧化指标及免疫指标,本试验条件下,最佳饲喂剂量为1%。     

益生菌制剂调控畜禽肠道健康与消化道微生物互作的免疫机制

益生菌制剂作为饲料添加剂,在维护畜禽机体肠道健康、菌群平衡以及营养生理方面发挥着极其重要的作用。一方面,益生菌制剂能够替代部分抗生素,为实现畜禽养殖过程中的"减抗"目标,开辟了一条优质、安全、绿色的道路;另一方面,益生菌制剂能够调控肠道生理结构和改善肠道屏障完整性,进而缓解畜禽养殖中的"亚健康"状况。本文围绕益生菌制剂的种类与作用,益生菌制剂对畜禽肠道免疫、应激、疾病的调控机制,益生菌制剂的发展前景进行阐述,为开发更多益生菌制剂的产品提供理论支撑。     

膜联蛋白B1在猪囊尾蚴免疫逃避作用的研究进展

膜联蛋白是一类有效的内源性调节蛋白,在Ca²⁺存在的条件下与膜磷脂结合,参与细胞活动的多种功能,其与肿瘤发生、自身免疫性疾病、病毒和寄生虫感染等密切相关。作为膜联蛋白家族成员Annexin B1具有独特的氨基酸残基结构,与不同种属的寄生虫入侵特异性宿主密切相关。本文主要阐述了膜联蛋白的种类及膜联蛋白B1在猪囊尾蚴感染宿主机体过程中免疫逃避的作用,旨在探索其猪囊尾蚴感染的免疫逃避机制。深入对膜联蛋白B1和囊尾蚴之间相互关系的进一步了解,以及膜联蛋白B1在寄生虫免疫中更深入的研究,对寄生虫免疫逃避的生物学意义和寄生虫病诊断治疗提供了相关的策略。     

E．stiedai感染兔免疫器官内球虫抗原的免疫组化定位

用免疫组化SABC法，对斯氏艾关耳球虫感染后兔肝脏、脾脏和肝门淋巴结中球虫抗原的分布进行了观察。结果表明，在肝脏窦状隙、胆管上皮细胞、肝门淋巴结和脾脏内可见到明显的呈棕黄色阳性反应区，表明在这些区域和部位有相应的E．stiedai孢子囊、裂殖子或子孢子抗原存在，且抗原数量以肝脏内最多，其次为脾脏，最少者为肝门淋巴结；显微镜下还可见到大量坏死的肝细胞、淋巴细胞以及朗罕氏巨细胞，说明多核巨细胞也参与了对球虫的吞噬和处理过程。